Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Wed, 21 Feb 18 18:59:56 +0000 Wed, 21 Feb 18 18:59:56 +0000 FDA Tentatively OKs Fixed-Dose HIV Combo Therapy http://www.pharmacytimes.com/product-news/fda-tentatively-oks-fixeddose-hiv-combo-therapy http://www.pharmacytimes.com/product-news/fda-tentatively-oks-fixeddose-hiv-combo-therapy Under the PEPFAR program, the antiretroviral (ARV) combination will be available in developing countries as a treatment for patients with HIV/AIDS. Wed, 21 Feb 18 07:58:00 +0000 What to Know About Working with PBMs http://www.pharmacytimes.com/news/what-to-know-about-working-with-pbms http://www.pharmacytimes.com/news/what-to-know-about-working-with-pbms A Pharmacy Benefit Manager (PBM) is a third party administrator contracted by health plans, employers, unions and government entities to manage prescription drug programs.&nbsp;A PBM acts as a fiscal intermediary between insurers/payors and pharmacies. Tue, 20 Feb 18 18:32:00 +0000 Understanding, Managing Immunotherapy Side Effects http://www.pharmacytimes.com/news/understanding-managing-immunotherapy-side-effects http://www.pharmacytimes.com/news/understanding-managing-immunotherapy-side-effects Immunotherapy-related side effects can occur at any time and can affect any organ. Mon, 19 Feb 18 16:41:00 +0000 Durvalumab Approved by FDA for Reducing NSCLC Progression http://www.pharmacytimes.com/news/durvalumab-approved-by-fda-for-reducing-nsclc-progression http://www.pharmacytimes.com/news/durvalumab-approved-by-fda-for-reducing-nsclc-progression The FDA recently approved durvalumab (Imfinzi) for the treatment of patients with stage 3 non-small cell lung cancer (NSCLC) whose tumors are unresectable and whose disease has not progressed following treatment with chemoradiation. Mon, 19 Feb 18 16:16:00 +0000 Breath-Actuated Aerosol for Asthma Maintenance Launches http://www.pharmacytimes.com/product-news/breathactuated-aerosol-for-asthma-maintenance-launches http://www.pharmacytimes.com/product-news/breathactuated-aerosol-for-asthma-maintenance-launches QVAR RediHaler is now commercially available to patients by prescription in 40 mcg and 80 mcg strengths. Sat, 17 Feb 18 11:55:00 +0000 New Prostate Cancer Drug Gets FDA OK http://www.pharmacytimes.com/product-news/new-prostate-cancer-drug-gets-fda-ok http://www.pharmacytimes.com/product-news/new-prostate-cancer-drug-gets-fda-ok Wed, 14 Feb 18 22:35:00 +0000 FDA OKs Combo Treatment for Cystic Fibrosis Caused by Certain Mutations http://www.pharmacytimes.com/product-news/fda-oks-combo-treatment-for-cystic-fibrosis-caused-by-certain-mutations http://www.pharmacytimes.com/product-news/fda-oks-combo-treatment-for-cystic-fibrosis-caused-by-certain-mutations FDA officials have approved tezacaftor/ivacaftor and ivacaftor (Symdeko, Vertex Pharmaceuticals) for the treatment of cystic fibrosis (CF) in individuals aged 12 years and older. Tue, 13 Feb 18 19:18:00 +0000 FDA Approves Generic Drug for Relapsing Multiple Sclerosis http://www.pharmacytimes.com/product-news/fda-approves-generic-drug-for-relapsing-multiple-sclerosis http://www.pharmacytimes.com/product-news/fda-approves-generic-drug-for-relapsing-multiple-sclerosis Officials with the FDA have approved Novartis&#39;&nbsp;glatiramer acetate injection (Glatopa) 40-mg/mL for the treatment of multiple sclerosis (MS). Tue, 13 Feb 18 14:28:00 +0000 Threat of Drug-Resistant E coli Increases with Pediatric Antibiotic Prescriptions http://www.pharmacytimes.com/news/threat-of-drugresistant-e-coli-increases-with-pediatric-antibiotic-prescriptions- http://www.pharmacytimes.com/news/threat-of-drugresistant-e-coli-increases-with-pediatric-antibiotic-prescriptions- Antibiotics may become ineffective in treating <em>E coli</em> if antibiotic resistance continues to increase among children. Mon, 12 Feb 18 14:00:00 +0000 Pharmacists Remain Among Most Trusted and Ethical Professionals http://www.pharmacytimes.com/news/pharmacists-remain-among-most-trusted-and-ethical-professionals http://www.pharmacytimes.com/news/pharmacists-remain-among-most-trusted-and-ethical-professionals Pharmacists have once again been ranked among the most honest and ethical professionals in the United States, according to the results of the latest Gallup poll on the topic. Fri, 09 Feb 18 14:00:00 +0000 QR Codes Make Their Way to Prescription Drugs http://www.pharmacytimes.com/news/qr-codes-make-their-way-to-prescription-drugs http://www.pharmacytimes.com/news/qr-codes-make-their-way-to-prescription-drugs An innovate production method may allow health care providers to produce on-demand medicine in the near future.<br /> &nbsp; Fri, 09 Feb 18 13:00:00 +0000 FDA Approves Castration-Sensitive Prostate Cancer Drug http://www.pharmacytimes.com/product-news/fda-approves-castrationsensitive-prostate-cancer-drug http://www.pharmacytimes.com/product-news/fda-approves-castrationsensitive-prostate-cancer-drug Officials with the FDA have granted approval to abiraterone acetate (Zytiga) tablets in combination with&nbsp;prednisone for the treatment of metastatic high-risk castration-sensitive prostate cancer (CSPC), according to a press release. Thu, 08 Feb 18 21:18:00 +0000 Combination Therapy That Includes Daratumumab Lowers Risk of Multiple Myeloma Progression http://www.pharmacytimes.com/news/combination-therapy-that-includes-daratumumab-lowers-risk-of-multiple-myeloma-progression http://www.pharmacytimes.com/news/combination-therapy-that-includes-daratumumab-lowers-risk-of-multiple-myeloma-progression Study results show patients with newly diagnosed multiple myeloma showed a lower risk of disease progression or death with daratumumab added to the standard regimen of bortezomib, melphalan and prednisone, than patients who were treated without daratumumab in their drug combination. Thu, 08 Feb 18 19:00:00 +0000 Hemophilia B Medication Made Available to Pharmacies http://www.pharmacytimes.com/product-news/hemophila-b-medication-made-available-to-pharmacies http://www.pharmacytimes.com/product-news/hemophila-b-medication-made-available-to-pharmacies A new medicine for treating hemophilia B, Rebinyn Coagulation Factor X (recombinant), GlycoPEGlated, has been made available to pharmacies.&nbsp; Thu, 08 Feb 18 16:44:00 +0000 FDA OKs 2 Fixed Dose HIV Treatments http://www.pharmacytimes.com/product-news/fda-oks-2-fixed-dose-hiv-treatments http://www.pharmacytimes.com/product-news/fda-oks-2-fixed-dose-hiv-treatments Officials with the FDA have approved 2 different fixed dose drugs indicated to treat HIV-1: Symfi Lo tablets&nbsp;and Biktarvy. Thu, 08 Feb 18 14:14:00 +0000 2 New Diabetes Medications Available for Treating Adults http://www.pharmacytimes.com/product-news/2-new-diabetes-medications-are-available-for-treating-adults http://www.pharmacytimes.com/product-news/2-new-diabetes-medications-are-available-for-treating-adults Wed, 07 Feb 18 15:57:00 +0000 FDA: Kratom Compounds Contain Opioid Properties http://www.pharmacytimes.com/product-news/fda-kratom-compounds-contain-opioid-properties http://www.pharmacytimes.com/product-news/fda-kratom-compounds-contain-opioid-properties In newly-released scientific analysis and data, the FDA has indicated strong evidence of the presence of compounds in kratom that strongly bind to opioid receptors, according to a statement released by FDA Commissioner Scott Gottlieb, MD.<br /> &nbsp; Wed, 07 Feb 18 14:55:00 +0000 First-Line Combo Immunotherapy Improves PFS in High TMB Non-Small Cell Lung Cancer http://www.pharmacytimes.com/product-news/firstline-combo-immunotherapy-improves-pfs-in-high-tmb-nonsmall-cell-lung-cancer http://www.pharmacytimes.com/product-news/firstline-combo-immunotherapy-improves-pfs-in-high-tmb-nonsmall-cell-lung-cancer The combination of nivolumab (Opdivo) and ipilimumab (Yervoy) improved progression-free survival (PFS) compared with chemotherapy in treatment-na&iuml;ve patients with high tumor mutation burden (TMB) non&ndash;small cell lung cancer (NSCLC). Mon, 05 Feb 18 14:03:00 +0000 FDA Updates HIV Drug Label to Include Dosing for Pregnant Patients http://www.pharmacytimes.com/product-news/fda-updates-hiv-drug-label-to-include-dosing-for-pregnant-patients http://www.pharmacytimes.com/product-news/fda-updates-hiv-drug-label-to-include-dosing-for-pregnant-patients The FDA updated the labeling for rilipivirine (Edurant) for the treatment of HIV-positive pregnant patients who were on stable treatment prior to conception and who are virologically suppressed.&nbsp; Sat, 03 Feb 18 17:30:00 +0000 Combo Inhibitor Antibiotic Approved to Treat HABP/VABP http://www.pharmacytimes.com/product-news/avycaz-approved-to-treat-habpvabp http://www.pharmacytimes.com/product-news/avycaz-approved-to-treat-habpvabp The US Food and Drug Administration has approved Allergan&#39;s supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms:&nbsp;Klebsiella pneumoniae,&nbsp;Enterobacter cloacae,&nbsp;Escherichia coli,&nbsp;Serratia marcescens,&nbsp;Proteus mirabilis,&nbsp;Pseudomonas aeruginosa, and&nbsp;Haemophilus influenzae&nbsp;in patients 18 years of age or older. Sat, 03 Feb 18 16:17:00 +0000 FDA Adds Boxed Warning to Liver Disease Medication for Correct Dosing http://www.pharmacytimes.com/product-news/fda-adds-boxed-warning-to-liver-disease-medication-for-correct-dosing http://www.pharmacytimes.com/product-news/fda-adds-boxed-warning-to-liver-disease-medication-for-correct-dosing Officials with the FDA have added a boxed warning label to liver disease medicine obeticholic acid (Ocaliva, Intercept) to highlight the correct dosing for patients with rare chronic liver disease, according to a FDA safety announcement.<br /> &nbsp; Thu, 01 Feb 18 19:39:00 +0000 CDC Director Resigns Amidst Tobacco Stock Controversy http://www.pharmacytimes.com/news/cdc-director-resigns-amidst-tobacco-stock-controversy http://www.pharmacytimes.com/news/cdc-director-resigns-amidst-tobacco-stock-controversy CDC director Brenda Fitzgerald, MD, resigned today following reports that she bought shares in a tobacco company during her tenure. Wed, 31 Jan 18 17:54:00 +0000 FDA Aims to Limit Packaging for Anti-Diarrhea Drug to Reduce Abuse, Misuse http://www.pharmacytimes.com/product-news/fda-aims-to-limit-packaging-for-antidiarrhea-drug-to-reduce-abuse-misuse http://www.pharmacytimes.com/product-news/fda-aims-to-limit-packaging-for-antidiarrhea-drug-to-reduce-abuse-misuse To encourage the safe use of the anti-diarrhea medicine loperamide (Imodium), the FDA is working to limit packaging for the medication through use of blister packs and other single-dose packaging. Tue, 30 Jan 18 18:41:00 +0000 Cigarette Use Continues to Decline Among Adults http://www.pharmacytimes.com/news/cigarette-use-continues-to-decline-among-adults http://www.pharmacytimes.com/news/cigarette-use-continues-to-decline-among-adults Despite progress made, smoking remains the leading cause of preventable death and disease among Americans.<br /> &nbsp; Tue, 30 Jan 18 13:56:00 +0000 FDA Approves Vancomycin Hydrochloride Oral Liquid Therapy for CDAD http://www.pharmacytimes.com/product-news/fda-approves-vancomycin-hydrochloride-oral-liquid-therapy-for-cdad http://www.pharmacytimes.com/product-news/fda-approves-vancomycin-hydrochloride-oral-liquid-therapy-for-cdad The availability of an oral liquid therapy is expected to improve patient access and reduce pharmacist burden of having to compound liquid formulations. Mon, 29 Jan 18 16:51:00 +0000